An integrated microdialysis rat model for multiple pharmacokinetic/pharmacodynamic investigations of serotonergic agents

Journal of Pharmacological and Toxicological Methods - Tập 55 Số 2 - Trang 214-223 - 2007
Christoffer Bundgaard1, Martin Grønbech Jørgensen2, Arne Mørk3
1Discovery ADME, H. Lundbeck A/S, Copenhagen, Denmark
2Early Development Pharmacokinetics, H. Lundbeck A/S, Copenhagen, Denmark
3Neurobiology, H. Lundbeck A/S, Copenhagen, Denmark

Tóm tắt

Từ khóa


Tài liệu tham khảo

Belayev, 1996, Quantitative evaluation of blood–brain barrier permeability following middle cerebral artery occlusion in rats, Brain Research, 739, 88, 10.1016/S0006-8993(96)00815-3

Bouw, 1998, Methodological aspects of the use of a calibrator in in vivo microdialysis — further development of the retrodialysis method, Pharmaceutical Research, 15, 1673, 10.1023/A:1011992125204

Bundgaard, C., Larsen, F., Jørgensen, M., & Gabrielsson, J. (in press). Mechanistic model of acute autoinhibitory feedback action after administration of SSRIs in rats: application to escitalopram-induced effects on brain serotonin levels. European Journal of Pharmaceutical Sciences.

Burgio, 1993, Evaluation of recovery and loss from microdialysis probes of benzodiazepines and antipyrine in vitro, Pharmaceutical Research, 10, 349

Ceglia, 2004, Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: Role of 5-HT1A receptors, British Journal of Pharmacology, 142, 469, 10.1038/sj.bjp.0705800

Cremers, 2000, Augmentation with a 5-HT1A, but not a 5-HT1B receptor antagonist critically depends on the dose of citalopram, European Journal of Pharmacology, 397, 63, 10.1016/S0014-2999(00)00247-8

Davies, 2000, Analytical considerations for microdialysis sampling, Advanced Drug Delivery Reviews, 45, 169, 10.1016/S0169-409X(00)00114-9

de Lange, 2005, Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic–pharmacodynamic modeling, AAPS Journal, 7, E532, 10.1208/aapsj070354

Diehl, 2001, A good practice guide to the administration of substances and removal of blood, including routes and volumes, Journal of Applied Toxicology, 21, 15, 10.1002/jat.727

Drijfhout, 1995, A telemetry study on the chronic effects of microdialysis probe implantation on the activity pattern and temperature rhythm of the rat, Journal of Neuroscience Methods, 61, 191, 10.1016/0165-0270(94)00041-E

Fagin, 1983, Effects of housing and chronic cannulation on plasma ACTH and corticosterone in the rat, American Journal of Physiology, 245, E515

Fox, 2002, Zidovudine concentration in brain extracellular fluid measured by microdialysis: steady-state and transient results in rhesus monkey, Journal of Pharmacology and Experimental Therapeutics, 301, 1003, 10.1124/jpet.301.3.1003

Groth, 1997, In vitro microdialysis of hydrophilic and lipophilic compounds, Analytica Chimica Acta, 355, 75, 10.1016/S0003-2670(97)81614-5

Gumbleton, 1991, Drug metabolism and laboratory anesthetic protocols in the rat: examination of antipyrine pharmacokinetics, Pharmaceutical Research, 8, 544, 10.1023/A:1015827917684

Gunaratna, 2004, An automated blood sampler for simultaneous sampling of systemic blood and brain microdialysates for drug absorption, distribution, metabolism, and elimination studies, Journal of Pharmacological and Toxicological Methods, 49, 57, 10.1016/S1056-8719(03)00058-3

Kugelberg, 2003, Stereoselective single-dose kinetics of citalopram and its metabolites in rats, Chirality, 15, 622, 10.1002/chir.10266

Le Quellec, 1995, Microdialysis probes calibration: gradient and tissue dependent changes in no net flux and reverse dialysis methods, Journal of Pharmacological and Toxicological Methods, 33, 11, 10.1016/1056-8719(94)00049-A

Loch, 1995, The influence of anesthetic agents on rat hepatic cytochromes P450 in vivo, Pharmacology, 50, 146, 10.1159/000139276

Lönnroth, 1987, A microdialysis method allowing characterization of intercellular water space in humans, American Journal of Physiology, 253, E228

Mørk, 2003, The R-enantiomer of citalopram counteracts escitalopram-induced increase in extracellular 5-HT in the frontal cortex of freely moving rats, Neuropharmacology, 45, 167, 10.1016/S0028-3908(03)00138-2

Olesen, 1999, Studies on the stereoselective metabolism of citalopram by human liver microsomes and cDNA-expressed cytochrome P450 enzymes, Pharmacology, 59, 298, 10.1159/000028333

Pardridge, 1998, CNS drug design based on principles of blood–brain barrier transport, Journal of Neurochemistry, 70, 1781, 10.1046/j.1471-4159.1998.70051781.x

Paxinos, 1986

Plock, 2005, Microdialysis — theoretical background and recent implementation in applied life-sciences, European Journal of Pharmaceutical Sciences, 25, 1, 10.1016/j.ejps.2005.01.017

Raap, 1999, Selective serotonin reuptake inhibitors and neuroendocrine function, Life Sciences, 65, 1217, 10.1016/S0024-3205(99)00169-1

Royo, 2004, Impact of chronic catheterization and automated blood sampling (Accusampler) on serum corticosterone and fecal immunoreactive corticosterone metabolites and immunoglobulin A in male rats, Journal of Endocrinology, 180, 145, 10.1677/joe.0.1800145

Sánchez, 2004, Escitalopram versus citalopram: the surprising role of the R-enantiomer, Psychopharmacology, 174, 163, 10.1007/s00213-004-1865-z

Schuck, 2004, In vitro microdialysis sampling of docetaxel, Journal of Pharmaceutical and Biomedical Analysis, 36, 807, 10.1016/j.jpba.2004.07.007

Shimizu, 1992, In vivo measurement of hypothalamic serotonin release by intracerebral microdialysis: significant enhancement by immobilization stress in rats, Brain Research Bulletin, 28, 727, 10.1016/0361-9230(92)90252-S

Sidhu, 1997, Steady-state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans, Chirality, 9, 686, 10.1002/(SICI)1520-636X(1997)9:7<686::AID-CHIR9>3.0.CO;2-5

Song, 1999, Comparison of calibration by delivery versus no net flux for quantitative in vivo microdialysis sampling, Analytica Chimica Acta, 379, 251, 10.1016/S0003-2670(98)00363-8

Stenken, 1999, Methods and issues in microdialysis calibration, Analytica Chimica Acta, 379, 337, 10.1016/S0003-2670(98)00598-4

Suzuki, 1997, Blood sampling technique for measurement of plasma arginine vasopressin concentration in conscious and unrestrained rats, Laboratory Animal Science, 47, 190

Tegeder, 1999, Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration, Clinical Pharmacology and Therapeutics, 65, 357, 10.1016/S0009-9236(99)70128-1

Thase, 2006, Managing depressive and anxiety disorders with escitalopram, Expert Opinion on Pharmacotherapy, 7, 429, 10.1517/14656566.7.4.429

Thorré, 1997, New antioxidant mixture for long term stability of serotonin, dopamine and their metabolites in automated microbore liquid chromatography with dual electrochemical detection, Journal of Chromatography. B, Biomedical Sciences and Applications, 694, 297, 10.1016/S0378-4347(97)00126-6

Vallée, 1996, Long-term effects of prenatal stress and handling on metabolic parameters: relationship to corticosterone secretion response, Brain Research, 712, 287, 10.1016/0006-8993(95)01459-4

van Dongen, 1990

Wang, 2006, An automated blood sampling system to measure lovastatin level in plasma and faeces, Biomedical Chromatography, 20, 911, 10.1002/bmc.618

Watanabe, 2002, The effect of immobilization stress on the pharmacokinetics of omeprazole in rats, Acta Medica Okayama, 56, 19

Wong, 1994, Analysis of corticosterone in rat plasma by high-performance liquid chromatography, Journal of Chromatography. B, Biomedical Sciences and Applications, 661, 211, 10.1016/0378-4347(94)00346-7

Woodward, 1987, Determination of plasma corticosterone using high-performance liquid chromatography, Journal of Chromatography, 419, 280, 10.1016/0378-4347(87)80287-6

Zuideveld, 2002, Pharmacokineticpharmacodynamic modelling of the hypothermic and corticosterone effects of the 5-HT1A receptor agonist flesinoxan, European Journal of Pharmacology, 445, 43, 10.1016/S0014-2999(02)01665-5